Evidence map›Paper›PMID 42455249›Full record

ReviewGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026

Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025).

Hidekazu Hirano, Yoichi Naito, Tsuyoshi Takahashi, Seiichi Hirota, Kyoung-Mee Kim, Min-Hee Ryu, Jian Wang, Hui Cao, Jian Li, Chien-Feng Li and 9 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Hidekazu HiranoDepartment of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Yoichi NaitoDepartment of General Internal Medicine/Experimental Therapeutics/Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
Tsuyoshi TakahashiDepartment of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Seiichi HirotaDepartment of Diagnostic Pathology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan.
Kyoung-Mee KimDepartment of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Min-Hee RyuDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Jian WangDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Hui CaoDepartment of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jian LiState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Cell & Gene Therapy for Solid Tumor, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
Chien-Feng LiNational Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
Chueh-Chuan YenDivision of Clinical Research, Department of Medical Research, and Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
Han-Kwang YangDepartment of Surgery, Seoul National University Hospital, Seoul, Republic of Korea.
Hwoon-Yong JungDepartment of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Chun-Nan YehDepartment of Surgery, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taipei, Taiwan.
Hsiu-Po WangDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Li-Tzong ChenDepartment of Internal Medicine, Kaohsiung Medical University Hospital, and College of Medicine and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ShenState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Cell & Gene Therapy for Solid Tumor, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
Yoon-Koo KangDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Toshirou NishidaDepartment of Surgery, Japan Community Healthcare Organization Osaka Hospital, 4-2-78, Fukushima, Fukushima-ku, Osaka, 553-0003, Japan. nishida-toshirou@osaka.jcho.go.jp.ORCID http://orcid.org/0000-0002-1542-6317

Funding

National Cancer Center Research and Development Fund 31-A-14
6 · The paper itself

Abstract

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor arising from the gastrointestinal tract. Accurate pathological diagnosis and appropriate treatment for this malignancy require a multidisciplinary approach. In consideration of the differences in clinical practice between Asian and Western countries, the Asian Consensus Guidelines for the Diagnosis and Management of GISTs were published in 2016 by multidisciplinary experts in Asian countries (Japan, Korea, China, and Taiwan). Given the accumulation of new evidence since the previous publication, a multidisciplinary expert panel consisting of pathologists, surgical oncologists, and medical oncologists revised the Asian consensus guidelines. This narrative review provides updated consensus recommendations reflecting available evidence, expert opinion, and current clinical practice for the diagnosis and management of GIST in Asian countries.

Indexed as

Gastrointestinal NeoplasmsGastrointestinal Stromal TumorsPractice Guidelines as TopicAsiaConsensusHumansAsiaConsensusDiagnosisGISTGuidelineTreatment

Identifiers

PMID42455249
PMCPMC13525072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.